Expert offers caveats to perioperative antirheumatic drug guidelineFebruary 23, 2023Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitisOrthopedics
New influx of Humira biosimilars may not drive immediate changeFebruary 22, 2023Rheumatoid ArthritisPsoriatic ArthritisBusiness of MedicineSpondyloarthropathiesAnkylosing spondylitis
Are repeat radiographs necessary in rheumatoid and psoriatic arthritis?February 16, 2023Rheumatoid ArthritisPsoriatic Arthritis
Health plans get very poor scores for access to autoimmune drugsFebruary 14, 2023Business of MedicineRheumatoid ArthritisLupus & Connective Tissue DiseasesPsoriatic Arthritis
Biosimilars perform identically to originator biologics in natural experimentFebruary 14, 2023Rheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitis
First Humira biosimilar launches in U.S.February 1, 2023Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitis
75 years: A look back on the fascinating history of methotrexate and folate antagonistsJanuary 26, 2023Rheumatoid ArthritisPsoriatic ArthritisPediatricsLupus & Connective Tissue Diseases
Teamwork guides cardio-rheumatology clinics that care for unique patient populationJanuary 23, 2023Business of MedicineGoutAnkylosing spondylitisLupus & Connective Tissue DiseasesPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
Cardiovascular risk score multipliers suggested for rheumatic diseasesDecember 21, 2022Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesAnkylosing spondylitis
FDA will review pediatric indication for roflumilast creamDecember 19, 2022PediatricsPsoriatic Arthritis
